|
⚲
|
| Keyboard |
| Marshall William Stuart
✚
|
|
|---|---|
| CIK # | 0001693127 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001693127] | |
| 4 | [0001693127] | |
| 5 | [0001693127] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Miragen Therapeutics Inc | |
| Marshall William Stuart |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miragen Therapeutics Inc MGEN
Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 464,000 | $0.00 | |
|
Miragen Therapeutics Inc MGEN
Common Stock
|
2019-08-21 | Grant | 1,250 | $1.14 | 1,425 |
|
Miragen Therapeutics Inc MGEN
Common Stock
|
2019-02-21 | Grant | 1,250 | $2.46 | 3,075 |
|
Miragen Therapeutics Inc MGEN
Stock Option (right to buy) · derivative
|
2019-02-06 | Grant | 232,000 | $0.00 | |
|
Miragen Therapeutics Inc MGEN
Stock Option (right to buy) · derivative
|
2018-02-13 | Option exercise | 115,818 | $0.00 | |
|
Miragen Therapeutics Inc MGEN
Common Stock
|
2018-02-13 | Option exercise | 115,818 | $0.57 | 66,016 |
|
Miragen Therapeutics Inc MGEN
Stock Option (right to buy) · derivative
|
2018-01-31 | Grant | 245,000 | $0.00 | |
|
Miragen Therapeutics Inc MGEN
Stock Option (right to buy) · derivative
|
2017-02-16 | Grant | 200,000 | $0.00 |